Cargando…
Modulation of sphingosine receptors influences circadian pattern of cardiac autonomic regulation
Fingolimod is an oral sphingosine‐1‐phospate (S1P) receptor modulator for the treatment of relapsing‐remitting multiple sclerosis (RRMS). In addition to therapeutic effects on lymphoid and neural tissue, fingolimod influences cardiovascular system by specific S1P‐receptor modulation. The effects of...
Autores principales: | Simula, Sakari, Laitinen, Tomi P., Laitinen, Tiina M., Hartikainen, Päivi, Hartikainen, Juha E. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027338/ https://www.ncbi.nlm.nih.gov/pubmed/27624686 http://dx.doi.org/10.14814/phy2.12870 |
Ejemplares similares
-
Cardiac repolarization during fingolimod treatment in patients with relapsing–remitting multiple sclerosis
por: Laiho, Aapo, et al.
Publicado: (2018) -
Mild obstructive sleep apnea does not modulate baroreflex sensitivity in adult patients
por: Blomster, Henry, et al.
Publicado: (2015) -
The impact of multiple sclerosis onset symptom on cardiac repolarization
por: Mikkola, Alma, et al.
Publicado: (2017) -
Test–Retest Reliability of the Assessment of Fatty Liver Disease Using Low-Dose Computed Tomography in Cardiac Patients
por: Hokkanen, Antti, et al.
Publicado: (2021) -
Grey matter atrophy in patients with benign multiple sclerosis
por: Niiranen, Marja, et al.
Publicado: (2022)